Clinically relevant drug interactions with multikinase inhibitors: a review von Hussaarts, Koen G. A. M., Veerman, G. D. Marijn, Jansman, Frank G. A., van Gelder, Teun, Mathijssen, Ron H. J., van Leeuwen, Roelof W. F.

Volltext

Improving the tolerability of osimertinib by identifying its toxic limit von Agema, Bram C., Veerman, G. D. Marijn, Steendam, Christi M. J., Lanser, Daan A. C., Preijers, Tim, van der Leest, Cor, Koch, Birgit C. P., Dingemans, Anne-Marie C., Mathijssen, Ron H. J., Koolen, Stijn L. W.

Volltext

Clinical implications of food–drug interactions with small-molecule kinase inhibitors von Veerman, G D Marijn, Hussaarts, Koen G A M, Jansman, Frank G A, Koolen, Stijn W L, van Leeuwen, Roelof W F, Mathijssen, Ron H J

Volltext

Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer von Veelen, Ard, Veerman, G. D. Marijn, Verschueren, Marjon V., Gulikers, Judith L., Steendam, Christi M. J., Brouns, Anita J. W. M., Dursun, Safiye, Paats, Marthe S., Tjan‐Heijnen, Vivianne C. G., Leest, Cor, Dingemans, Anne‐Marie C., Mathijssen, Ron H. J., Garde, Ewoudt M. W., Souverein, Patrick, Driessen, Johanna H. M., Hendriks, Lizza E. L., Geel, Robin M. J. M., Croes, Sander

Volltext

Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib von Yin, Anyue, Veerman, G. D. Marijn, Hasselt, Johan G. C., Steendam, Christi M. J., Dubbink, Hendrikus Jan, Guchelaar, Henk‐Jan, Friberg, Lena E., Dingemans, Anne‐Marie C., Mathijssen, Ron H. J., Moes, Dirk Jan A. R.

Volltext

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer von Steendam, Christi M J, Veerman, G D Marijn, Pruis, Melinda A, Atmodimedjo, Peggy, Paats, Marthe S, van der Leest, Cor, von der Thüsen, Jan H, Yick, David C Y, Oomen-de Hoop, Esther, Koolen, Stijn L W, Dinjens, Winand N M, van Schaik, Ron H N, Mathijssen, Ron H J, Aerts, Joachim G J V, Dubbink, Hendrikus Jan, Dingemans, Anne-Marie C

Volltext

Quantification of afatinib, alectinib, crizotinib and osimertinib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry; focusing on the stability of osimert... von Veerman, G.D. Marijn, Lam, Mei H., Mathijssen, Ron H.J., Koolen, Stijn L.W., de Bruijn, Peter

Volltext

Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib von Brouns, Anita J.W. M., van Veelen, Ard, Veerman, G. D. Marijn, Steendam, Christi, Dursun, Safiye, van der Leest, Cor, Croes, Sander, Dingemans, Anne-Marie C., Hendriks, Lizza E.L.

Volltext

Comparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabine von de Man, Femke M., Veerman, G.D. Marijn, Oomen-de Hoop, Esther, Deenen, Maarten J., Meulendijks, Didier, Mandigers, Caroline M.P.W., Soesan, Marcel, Schellens, Jan H.M., van Meerten, Esther, van Gelder, Teun, Mathijssen, Ron H.J.

Volltext

Diagnosis and quantification of bronchiectasis using computed tomography or magnetic resonance imaging: A systematic review von Meerburg, Jennifer J., Veerman, G.D. Marijn, Aliberti, Stefano, Tiddens, Harm A.W.M.

Volltext

Quantitation of osimertinib, alectinib and lorlatinib in human cerebrospinal fluid by UPLC-MS/MS von de Leeuw, Simon P., de Bruijn, Peter, Koolen, Stijn L.W., Dingemans, Anne-Marie C., Mathijssen, Ron H.J., Veerman, G.D. Marijn

Volltext

Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis von Dammeijer, Floris, Lievense, Lysanne A, Veerman, G D Marijn, Hoogsteden, Henk C, Hegmans, Joost P, Arends, Lidia R, Aerts, Joachim G

Volltext

Clinical implications of germline variations for treatment outcome and drug resistance for small molecule kinase inhibitors in patients with non-small cell lung cancer von Heersche, Niels, Veerman, G.D. Marijn, de With, Mirjam, Bins, Sander, Assaraf, Yehuda G., Dingemans, Anne-Marie C., van Schaik, Ron H.N., Mathijssen, Ron H.J., Jansman, Frank G.A.

Volltext

Design and statistics of pharmacokinetic drug-drug, herb-drug, and food-drug interaction studies in oncology patients von Lanser, Daan A.C., Van der Kleij, Maud B.A., Veerman, G.D. Marijn, Steeghs, Neeltje, Huitema, Alwin D.R., Mathijssen, Ron H.J., Oomen-de Hoop, Esther

Volltext

To quantify the small-molecule kinase inhibitors ceritinib, dacomitinib, lorlatinib, and nintedanib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry von Veerman, G.D. Marijn, de Bruijn, Peter, Dingemans, Anne-Marie C., Mathijssen, Ron H.J., Koolen, Stijn L.W.

Volltext

Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer von de Leeuw, Simon P., Pruis, Melinda A., Sikkema, Barend J., Mohseni, Mostafa, Veerman, G. D. Marijn, Paats, Marthe S., Dumoulin, Daphne W., Smit, Egbert F., Schols, Annemie M.W. J., Mathijssen, Ron H.J., van Rossum, Elisabeth F.C., Dingemans, Anne-Marie C.

Volltext

The influence of green tea extract on nintedanib’s bioavailability in patients with pulmonary fibrosis von Veerman, G.D.Marijn, van der Werff, Sanne C., Koolen, Stijn L.W., Miedema, Jelle R., Oomen-de Hoop, Esther, van der Mark, Sophie C., Chandoesing, Prewesh P., de Bruijn, Peter, Wijsenbeek, Marlies S., Mathijssen, Ron H.J.

Volltext

Influence of esomeprazole on the bioavailability of afatinib: A pharmacokinetic cross-over study in patients with non-small cell lung cancer von Veerman, G.D. Marijn, Hurkmans, Daan P., Paats, Marthe S., Oomen-de Hoop, Esther, van der Leest, Cor H., van Thiel, Eric R.E., Aerts, Joachim G.J.V., van Leeuwen, Roelof W., Dingemans, Anne-Marie C., Mathijssen, Ron H.J.

Volltext

Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical application von Braal, C. Louwrens, Veerman, G.D. Marijn, Peric, Robert, Aerts, Joachim G.J.V., Mathijssen, Ron H.J., Koolen, Stijn L.W., de Bruijn, Peter

Volltext

Influence of Cow’s Milk and Esomeprazole on the Absorption of Erlotinib: A Randomized, Crossover Pharmacokinetic Study in Lung Cancer Patients von Veerman, G. D. Marijn, Hussaarts, Koen G. A. M., Peric, Robert, Oomen-de Hoop, Esther, Landa, Kersten D., van der Leest, Cor H., Broerse, Suzanna D., Rutten, Hugo B., Belderbos, Huub N. A., Steendam, Christi M. J., Paats, Marthe S., Koolen, Stijn L. W., Dingemans, Anne-Marie C., van Gelder, Teun, van Leeuwen, Roelof W. F., Aerts, Joachim G. J. V., Mathijssen, Ron H. J.

Volltext